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As part of a multicentre study on kidney disease (ARK) undertaken in Malawi, South 
Africa and Uganda we undertook a social science component in Uganda to gather 
information on people’s understandings and perceptions of a diagnosis of kidney 
dysfunction, treatment and treatment seeking.  We recruited 46 people who had been 
given information about kidney dysfunction and had been found to have some, usually 
early, signs of mild impairment.  Data were collected during two in-depth interviews.  
Most participants had heard of the condition, but half denied knowledge of the health 
status of their kidneys or receiving results of tests from the clinic team.  This response 
may have been linked to a lack of symptoms, for those with early stage kidney 
dysfunction. The treatment people reported receiving caused some uncertainty about 
condition severity. This may be because several people were treated for other 
conditions (such as urinary tract infections) and did not require treatment specifically for 
kidney disease.  In our study, participants assessed illness severity based on symptoms 
and treatment and compared with the progression of other conditions. 
Key words: Kidney dysfunction; kidney impairment; Non-communicable 





Chronic kidney disease is a long-term condition with few symptoms until it is very 
advanced, and the symptoms are non-specific. The causes of kidney disease in sub-
Saharan Africa are poorly understood, but it appears to be a consequence of a number 
of factors, including some genetic traits endemic to the region such as sickle cell 
disease, and other glomerulonephritides, and emerging non-communicable conditions 
(diabetes, hypertension and obesity) (Ene-Iordache et al., 2016; Jha et al., 2013; 
Kalyesubula et al., 2017). Infectious diseases, including HIV-associated kidney disease 
and other factors such as herbal remedies are also thought to be important in 
susceptibility to kidney disease (Jha, et al., 2013; Naicker, Rahmanian, & Kopp, 2015; 
Perico and Remuzzi, 2014). 
Public knowledge levels on the normal functioning of the kidney in places such as the 
United Kingdom and the United States are limited (Gaffney et al., 2014; Kazley, 
Johnson, Simpson, Chavin, & Baliga, 2014; Slevin and Taylor, 2015).  In  a meta-
analysis and systematic review of patient experience of a chronic kidney disease 
diagnosis Teasdale and colleagues (2017) documented limited understanding of kidney 
disease, with a wide-range of beliefs on the causes of disease and concerns about 
progression among patients participating in qualitative research studies in the United 
States, Australia, Brazil, Canada, the Netherlands, Taiwan and Sweden.  A large cross-
sectional survey in 12 countries spread across six regions also showed limited 
awareness of chronic kidney disease among people who were at risk of the disease 
(Ene-Iordache, et al., 2016).  Kazley and colleagues (2014) asked health care providers 
in the United States about the knowledge and response to diagnosis of their African 
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American patients in South Carolina.  Those providers reported that most of their 
patients denied having the condition and were reluctant to undergo treatment.   
A systematic review, published in 2014, showed that the overall prevalence of chronic 
kidney disease in sub-Saharan Africa (sSA) was 13.9% (95% CI 12.2-15.7) (Stanifer et 
al., 2014). However, the true prevalence is unknown as these studies were drawn from 
convenience samples, often in hospitals or populations at high-risk for kidney disease, 
as well as uncertainty about how to estimate kidney function in sSA (Kalyesubula et al., 
2018). The search for an accurate measure has over the last two decades resulted in 
several equations being developed to estimate Glomerular Filtration Rate (GFR) based 
on levels of serum creatinine, an endogenous breakdown product of creatine phosphate 
produced by muscle which provides information on kidney function. However, the 
equations to estimate GFR were developed among populations with a low proportion of 
ethnic Africans and these equations have had limited validation among people in sSA 
(Kalyesubula, et al., 2018).  The accuracy of these equations is likely to be poor since 
serum creatinine levels vary substantially with race, diet and nutritional status 
(Delanaye, Mariat, Maillard, Krzesinski, & Cavalier, 2011).   
To address the gaps in knowledge regarding risk for kidney disease, kidney disease 
prevalence and optimal measurement of kidney function in sSA, a multicentre study, the 
African Research on Kidney Disease (ARK) Study (Kalyesubula et al., 2020), was 
recently undertaken in Malawi, South Africa and Uganda. All participating sites are 
Health and Demographic Surveillance sites, enabling a cross-sectional population-
based determination of the prevalence of kidney dysfunction in adults from 20 to 80 
years of age, followed by direct measurement of GFR using the excretion of intravenous 
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iohexol to examine the accuracy of different estimating equations for GFR (eGFR) 
(Fabian, Kalyesubula, Tomlinson, Crampin, & Naicker, 2019).  Previous studies using 
iohexol to measure GFR in sSA had been relatively small and included few people with 
impaired kidney function (Bukabau et al., 2018; Sagou Yayo et al., 2016; Wyatt et al., 
2013).   
In Uganda this survey was embedded within the General Population Cohort in a rural 
sub-county in Kalungu District, central Uganda, about 150 kilometres south of Kampala.  
The cohort was established 30 years ago, initially for the study of the epidemiology of 
HIV and AIDS, but in recent years the research focus has broadened to include other 
chronic communicable and non-communicable conditions. From 1990 the cohort 
participants were followed up annually, however since 2011 follow-up has been biennial 
(Asiki et al., 2013).  
A social science component of the ARK Study was embedded within the Ugandan site 
with the aim of gathering information on people’s understanding of information on 
kidney disease and perceptions of a diagnosis of kidney disease, treatment and 
treatment seeking.  In this paper we report the findings from this social science 
component. 
Most of the participants who were told that they were in the early stages of impaired 
kidney function in our study population had an asymptomatic condition, which did not at 
that time require specific treatment. We therefore focus in this paper on people’s 
understanding of kidney disease and their response to the information they were given 
on disease, as well as treatment and management of kidney disease. 
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We draw on the work of Leventhal and colleagues (Leventhal, Phillips, & Burns, 2016) 
and concepts from the `Common-Sense Model of Self-Regulation’ in our discussion of 
how the response to information on an asymptomatic chronic condition (at an early 
stage of potential disease) may be shaped by the experience of people’s knowledge of 
acute conditions, including an understanding of symptoms and expectations of a short 
time-line for the illness development.  In this regard, the early stages of kidney disease 
may mirror the early experience of HIV-infection, with which one may live for months or 
years without experiencing ill-health, or when sickness occurs it is not necessarily linked 
to symptoms that identify a specific condition (Willard et al., 2009). So, a person may 
not realise that they have the condition unless tested and diagnosed by a health-worker, 
which may not happen at a primary health centre if symptoms are non-specific.  The 
reference here to HIV is also relevant because this study took place in an area that was 
at one stage the epi-centre of the HIV epidemic; this may in itself influence expectations 
about disease progression and treatment approaches.  
Methods 
As noted above, the study area is in rural central Uganda.  The local livelihoods are 
based mainly around agriculture with families growing crops such as coffee, tobacco, 
bananas, beans, maize, potatoes and cassava.  Migration by some family members 
(younger women and men) to urban areas and fishing sites for wage work is common.  
Income is also made from making bricks, growing eucalyptus (and some pine) for sale 
and jobs in shops and bars in trading centres.  The main ethnic group in the study area 
is the Baganda with some immigrants originating from Rwanda and Tanzania. Most of 
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the population are Roman Catholics and the rest are Protestants and Muslims. Luganda 
is the main language spoken.   
The study focused on people who as part of the ARK study had been given information 
about kidney dysfunction and had been found to have some, usually early, signs of 
impairment (most people in the sample were asymptomatic), exploring their reaction to  
being given this information, and their understanding of kidney dysfunction and 
(possible future) treatment. We recruited a random sample of 46 people from among 
those who were found to have estimated GFR <90mls/min/1.73m2 during the 
recruitment of the 1000 participants for the iohexol component of the ARK Study 
(Kalyesubula, et al., 2018). We did not confirm that kidney function remained at this 
level or below after three months which would be required to formally diagnose Chronic 
Kidney Disease (Kalyesubula, et al., 2018).  Data were collected during two in-depth 
interviews with each participant.  The first interview was used to ask about day to day 
life, recent life history events and begin to talk about health seeking behaviour.  The 
second interview built on this information and probed more extensively for information 
around health seeking, use of traditional treatments and awareness of kidney 
impairment prior to the screening for this study.   
Most interviews were conducted at the participants’ homes.  Some participants chose to 
be interviewed at the clinic.  The interviews were conducted by two Ugandan 
interviewers (a man and a woman) with experience in qualitative data collection 
methods. The interviews were conducted in the local language (Luganda) and lasted up 
to one hour. Besides audio-recording the interviews, interviewers took field notes.  The 
interviewers transcribed the interviews and translated them into English. The transcripts 
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were reviewed throughout the course of the study by a senior social scientist, to ensure 
quality and provide continuous feedback on interview content and format.    
 
Data analysis  
Data from 46 participants were included in the final analysis for this paper.   A manual 
thematic content analysis approach, guided by the research questions listed above and 
constructs emerging from the data, was used to distil key concepts from the interviews. 
At the first level of analysis, the interviews were read repeatedly by the interviewers (EK 
and JSs) and a senior social scientist (DB), and then coded by EK and JSs, in 
consultation with DB and JS. Following the coding,  EK and JSs prepared detailed 
analytical memos on reactions to information on kidney disease; being given information 
on their own kidney dysfunction; offers of treatment and their own treatment seeking. 
From these narratives JS, DB, EK and JSs distilled the findings for this paper.  
 
Ethical Considerations 
Ethics approvals were obtained from the Uganda Virus Research Institute, Research 
Ethics Committee (UVRI-REC) and the Uganda National Council for Science and 
Technology (UNCST). 
If medical conditions were diagnosed through study screening, the participants were 
referred to appropriate medical facilities including the local study clinic which had 
enhanced resources as a result of the ongoing research work. With regards to this 
study, where most participants were found to have only mild impairment of kidney 
function, those in need of follow-up were referred to the local clinic, while participants 
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found to have advanced impairment were referred to appropriate nephrology services 
as directed by the study physicians (Kalyesubula, et al., 2020).  
Results 
The majority of participants in the social science study sample were classified as having 
Stage 2 kidney dysfunction according to the staging given by Kidney Disease Improving 
Global Outcomes (KDIGO) CKD Work Group (Kidney Disease Improving Global 
Outcomes (KDIGO) CKD Work Group, 2013). People with Stage 2 kidney dysfunction 
do not usually require treatment unless there are complications because of another 
condition. Any treatment provided depends on risk factors (linked to diabetes or 
hypertension) and whether specific investigations are needed for kidney disease.   
Table 1 provides an overview of the kidney disease staging, age and sex of participants 









30-39 years 40-49 years 50-59 years 60-69 years 70-79 years 80 years and over Total 
Male Female Male Female Male Female Male Female Male Female Male female  
2 2 2  8 2 10 2 6 2 3 3 1 41 
3a      1   1    2 
3b       1      1 
4     1        1 
5   1          1 
Total 2 2 1 8 3 11 3 6 3 3 3 1 46 
* The staging level of kidney dysfunction was based on one measure of eGFR.  The five stages of CKD, GFR and treatment for each stage are: 
• (Stage 1 – with normal or high GFR (GFR > 90 ml/min/1.73m2). No treatment necessary) 
• Stage 2 – mild CKD (GFR = 60-89 ml/min/1.73m2). Advice on healthy lifestyle: maintaining a healthy weight, smoking 
cessation, exercise levels. Monitoring and treating blood pressure, diabetes and other comorbidities.  
• Stage 3A – moderate CKD (GFR = 45-59 ml/min/1.73m2).  As Stage 2  
• Stage 3B – moderate CKD (GFR = 30-44 ml/min/1.73m2). As Stage 2 
• Stage 4 – Severe CKD (GFR = 15-29 ml/min/1.73m2).  As Stage 2. Management of fluid balance, blood pressure, anaemia, 
bone health and dietary changes may be required. . 
• Stage 5 – End stage CKD (GFR = <15 ml/min/1.73m2).  Management of fluid balance, blood pressure, anaemia, bone health 





We present the results in three parts: the reactions participants had to information on 
kidney dysfunction, their reactions to information on kidney disease and then their views 
on any treatment they may have been offered.  Many of those who participated in the 
study agreed to take part, not because they had symptoms, but because they saw the 
survey as an opportunity to have their health assessed for free by health workers from 
an organisation which they had known for many years.  This is summed up by one 40-
49 year old man who said: 
‘I have grown up seeing the organization treating people who were down because 
of HIV and enabling them become healthy once again although not being healed 
completely. Now hearing that those kidney disease researchers were health 
workers coming from the same organization, I could not hesitate to take part.’  
 
Reactions to being given information on kidney dysfunction 
Nearly all the people who were told that they have some signs of kidney dysfunction 
said that they had heard about the condition before the study began.  This level of 
knowledge was unexpected but could be explained by people having been told about 
the condition when seeking care for other conditions or knowing of relatives who had 
been given information on the condition or conditions, which sounded similar.   One 
woman, for example, who was living with HIV, said that she had been diagnosed with 
kidney problems in the past and had learnt of the condition through that experience.  
However, knowing the name of the condition did not, for most people, mean that they 
had a detailed knowledge of the condition:  
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‘I never knew that being diabetic or hypertensive could also lead to having the 
kidney disease, […] I am not aware and that persuaded me to take part.’  60-69 
year old man – Stage 2.  
The information provided on kidney disease during study mobilisation within the GPC 
led a few people to join the study because of health concerns that they had: 
‘It (kidney disease) is linked to severe back ache and due to what I heard about 
the sickness and I was also disturbed by the back pain I decided to test and find 
out if I have a kidney problem.’ 80+ year old man, – Stage 2. 
‘What mostly made me accept to participate is the swelling of the legs I experience 
at times which make me suspect that I could be a kidney patient too. I was even 
forced to ask the health worker about it but he (the health worker) comforted me 
not to worry and that I would get to know if the swelling was connected to that after 
the results come back.’ 40-49 year old woman. – Stage 2. 
The information provided to the participants made it clear that if someone had chronic 
kidney disease it was a serious condition.  About half of the participants said that when 
kidney dysfunction was first described to them, and participation in the study offered, 
they were very concerned that if they were found to have it, they would not be able to 
finance their own treatment.  Some said that they joined the study to access free 
treatment for that reason.  
‘I looked at my health and economic status; I am not all that well. I am disturbed by 
sickness yet I am poor. What if I have the kidney disease and I refuse to 
participate? Then later I get to know I am affected. Where do I begin from since 
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even the money for just the daily commodities is hard for me to obtain! I decided to 
take part because of that!’  50-59 year old woman – Stage 2. 
The information on the seriousness of chronic kidney disease, shared by the study 
team, was in some cases conflated with information that people had received from other 
sources, which raised the concern of some participants who perceived the condition as 
an acute health threat:  
‘I had feared very much to be among those whose kidneys are affected because 
one of my relatives had already told me that once the kidney or the liver become 
infected, chances are very limited for one to survive. I know death comes to 
everyone but I fear dying from such a serious illness!’  70-79 year old woman – 
Stage 2. 
Participants worried not only about themselves receiving a diagnosis of kidney 
impairment, but that their relatives and friends may have similar health problems.   
Concerns about the prevalence of the condition, as well as the fears over the condition 
being incurable, mirror continued anxiety about HIV in this population (Bukenya et al., 
2017).   
 
Reactions to being told of evidence that a person had kidney dysfunction 
 
All 46 participants told that they have some level of impaired kidney function, were given 
this information by study clinic staff and the condition explained to them.  However, 
when talking to the social science interviewers, more than half of the participants 
(26/46) said that they did not have kidney dysfunction. Of these, 14 people said that 
they had not received their results and a further 10 said that the results they received 
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had not indicated that they had such a condition. Two participants said that they had not 
taken part in the kidney disease screening exercise at all.  Both men and women 
expressed these views:  
 ‘They brought some information on a piece of paper. Unfortunately, I was away for 
my work then they handed the paper to mzee (meaning his father) […] I currently 
do not know where he placed that piece of paper.’ 40-49 year old man – Stage 5. 
Interestingly this man also commented that his father had told him his kidneys `were 
fine’.   
  
‘The health workers are the ones who know what they found. They are the ones 
who know what they are doing but have not disclosed to me what they found. 
Whether I am sick (with kidney problems) or not, I do not know.’ 70-79 year old 
woman – Stage 2. 
The health worker team confirmed that all the people sampled for the social science 
component had received information on the stage of kidney disease they had been 
identified with and results were only given to the participant, not to family members, 
which suggests the denial of receiving and knowing about this information was linked to 
worry about the condition. 
 
A fear of the condition was expressed by others who acknowledged being told that they 
had kidney dysfunction, but they said that the diagnosis was unexpected.  Some of 
these participants recalled that they had been told that the condition was not curable, 
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and they worried about the high cost of treatment and how family members would 
manage if they became very ill.    
‘After getting the results, I am just there, I am completely losing strength. I am 
worried.  You know each time you learn you have an illness you never 
anticipated; you become worried, your peace is as if taken away’. 60-69 year old 
man – Stage 3b. 
Some wished they could have had their condition verified in a different health facility.  A 
50-59 year old woman mentioned others who sought such support: 
`I did not have money for I would have gone to meet health workers elsewhere 
and find out what they would tell me about the same [kidney] issue because even 
my co- wife down there, who was invited in the same group, her well off children 
took her to Kampala for further investigation.’  - Stage 3a 
 
Six people said that they had been diagnosed with kidney dysfunction but they were 
doubtful that the diagnosis was correct. The reasons they doubted the diagnosis was 
because the test had been `very simple’, so they did not understand how such a test 
could diagnose a kidney disease.   But also, they did not have any symptoms like pain 
around the lower abdomen where the kidneys are located. This suggests that the way 
the condition was diagnosed led to people questioning what had actually been tested.  
They also said that the health workers had provided limited advice on what to do to 
manage progression, which they would have expected if the disease was severe. 
‘If I was sick with the kidneys, why did the health workers at your place [study 
clinic] not prevent me from taking salt? They have not even told me about other 
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things I should avoid if they found out that my kidney was sick. If they have not 
done so, have they not just put me in a worrying situation?’ 70-79 year old woman. 
Stage 3a. 
However, 10 people did react positively to news of their condition. Of these, eight 
reported that they accepted the information and had linked to care at a local health 
facility where their condition could be monitored and treatment provided if required, as 
advised by the health workers. If more specialist care was needed, health facility staff 
could refer patients to specialists at district and regional hospitals.  In addition to linking 
to formal health care, five of the ten people  said that they had disclosed their reduced 
kidney function diagnosis to their spouses, adult children or siblings.  The two people, 
both older men (in their 60s and 80s respectively), who had not linked to care said that 
they were contemplating the possibility of doing so ‘one day’. 
 
Reactions to advice on treatment. 
Given that half of the participants who had been found with kidney dysfunction had 
denied their diagnosis, it is not surprising that they also said that they were not 
accessing treatment.  However, it is also very likely that they were participants who had 
only mild to moderate kidney impairment, and no treatment had been recommended for 
them.  The lack of treatment may have led to doubts about their diagnosis, and hence a 
view that they were not affected.  In addition, some participants were offered treatment 
for other conditions (urinary tract infections for example), rather than directly for kidney 




The differences in treatment offered, referred to above, was confusing for some people.  
A few participants (four people) expressed their doubts about whether the treatment 
given in the study clinic was effective because of the short duration of treatment relative 
to the severity of the condition: 
‘They were just minor tablets which I took for only a week. I then kept wondering, 
how someone they have said has kidney disease can be given such minor 
treatment, yet they say the kidney disease is very bad, I was not satisfied!’ She 
continued; ‘just such tablets to treat a serious disease!’ 70-79 year old woman. – 
Stage 2. 
Given that this woman did not require any treatment for kidney dysfunction it is likely 
that this woman had received treatment for a urinary tract infection; if she had kidney 
disease she would have had follow-up visits to the clinic and if the condition was severe, 
referral to another facility. 
The short duration treatment for other conditions resulted in some people being very 
positive about `kidney disease treatment’.  Five people were happy about the limited 
treatment they received and said that they had adhered to the treatment.  
 ‘They told me `your illness is about the kidney! Your kidneys have lots of fluids!’ 
They started giving me drugs […] The drugs I got from [the study clinic] were for 
two weeks and I took them.’ 60-69 year old man. – Stage 3b. 
Nine of those who did disclose their condition to the social science interviewers said that 
they were seeking alternative forms of treatment in combination with the medication 
they received from the study clinic. The decision to use alternative medicine, herbs for 
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example, was mostly due to the influence of friends and relatives.  The same man who 
had received the treatment for two weeks, went on to say:  
‘I was taking tablets from the study clinic but then a friend directed/advised me to 
take some of that older woman’s herbs because she is well known for treating 
many illnesses. What I did was to take the tablets first then after two hours I would 
take the herbal medicine so that it does not interfere with the tablets.’ – Stage 3b. 
A 60-69 year old woman, who was assessed as `Stage 2’ so would not have required 
specific treatment for kidney dysfunction explained her use of herbs for a condition 
treated at the clinic: 
‘Since I completed the dosage [unspecified] I obtained from the study clinic, I have 
been taking powder made from rosemary adding it to hot water. I learnt from that 
young person (indicating someone nearby) that the herb has a lot of benefits which 
include brain boosting’.   
To sum up, we found that among people told that they had impaired kidney function, the 
majority had heard of the condition,  but half denied knowledge of the health status of 
their kidneys or, in some cases, receiving any results of tests from the clinic team.  The 
denial of the condition and delay or refusal to link to care may have been linked to a 
lack of symptoms for those with early stage kidney dysfunction, which may have led 
them to assume the information on kidney dysfunction to be incorrect.  The range of 
treatments given to people who did report both being given information and treatment, 
caused some uncertainty about whether the condition was indeed serious.  This was 
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probably because several people were treated for other conditions (such as urinary tract 
infections) and did not require treatment specifically for kidney disease.  
Discussion 
Our findings suggest that there was limited understanding of kidney dysfunction among 
those told about the condition, a result which mirrors the findings of studies from 
elsewhere (Ene-Iordache, et al., 2016; Kazley, et al., 2014; Slevin and Taylor, 2015; 
Teasdale, et al., 2017; Wright Nunes, Roney, Kerr, Ojo, & Fagerlin, 2016).   The lack of 
symptoms experienced by many of those who were told that they had impaired kidneys 
led them to doubt that they had the condition, a finding also corroborated elsewhere 
(Kazley, et al., 2014).  Receiving a diagnosis provides a label for a condition, affording 
`permission’ to be ill (Jutel, 2009) and the packaging of symptoms with a label for 
treatment (Rosenberg, 2002).  But when the condition is asymptomatic, a diagnosis 
may not provide confirmation of a condition, instead it can promote anxiety and disbelief 
(Walker and Rogers, 2017; Wright Nunes, et al., 2016).  A desire on the part of a 
medical practitioners not to alarm a patient or overburden someone with other non-
communicable conditions with a diagnosis of asymptomatic kidney disease may result 
in non or partial disclosure (Crinson, Gallagher, Thomas, & de Lusignan, 2010; Daker-
White et al., 2015; Nash, Garg, Brimble, & Markle-Reid, 2018).  It is also important to 
note that there is some uncertainty over the interpretation of kidney dysfunction in older 
people (Hart and Anderson, 2018; Nguyen and Goldfarb, 2012).  Many of our 
respondents were over 60 years of age and mild kidney impairment may have been part 
of the ageing process and the staging provided during the study was not confirmed with 




Other research in the UK and Australia shows that perceptions of chronic kidney 
disease, informed by the information that patients have on the condition, shapes 
patients wellbeing and their response to treatment (Kazley, et al., 2014), as well as 
influencing health outcomes (Chilcot, 2012).  Indeed, Nash and colleagues (Nash, et al., 
2018) argue for greater attention in primary care facilities to the process of diagnosis to 
improve the quality of care, based on their findings from Canada. 
 
In our study setting in Uganda, improving the rates of early diagnosis and treatment is 
important given access to, and affordability of, dialysis treatment for later stage kidney 
disease. Based on our findings several other factors affect the ways in which people 
react to a diagnosis, particularly a diagnosis which may be symptomless and `chronic’.  
Leventhal and colleagues (Leventhal, et al., 2016) in their  `Common-sense model of 
illness self-management’ describe how a model of acute illness shapes the way in 
which people respond to being diagnosed with a chronic condition.   An acute illness is 
generally characterised by symptoms which cause someone to seek care, from a health 
service provider or to self-treat.  In contrast, many chronic conditions are asymptomatic 
but `the acute model leads patients to expect symptoms and a short time-line’ (p.939) 
(Leventhal, et al., 2016), which is an approach that does not fit with the long-term 
management of asymptomatic progression.  A delay in seeking care is often attributed 
to the lack of symptoms for conditions such as hypertension and diabetes (Musinguzi et 
al., 2018; Nnko et al., 2015; Rutebemberwa, Katureebe, Gitta, Mwaka, & Atuyambe, 
2013) but also for people living with HIV, before they experience significant illness as a 
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result of the infection (Kawuma, Seeley, Mupambireyi, Cowan, & Bernays, 2018; Seeley 
et al., 2019).  Many infectious diseases, common in the Ugandan setting (malaria for 
example), provide symptoms which lead the person affected to seek immediate 
treatment (Ladner, Davis, Audureau, & Saba, 2017).  As Leventhal and colleagues 
(Leventhal, et al., 2016) note `patients will not take drugs unless they perceive a need to 
do so, particularly if asymptomatic’ (p939), in addition they may not, as we show in our 
findings, acknowledge that they have been told they have a condition, if they have no 
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